Summary & Overview
HCPCS C1608: Prosthesis, Total Dual Mobility, First Carpometacarpal Joint
HCPCS Level II code C1608 designates an implantable total dual-mobility prosthesis for the first carpometacarpal joint (the thumb base). It matters nationally as the aging population and demand for hand and thumb reconstructive procedures grow; a specific HCPCS Level II code supports consistent reporting, billing, and tracking of device utilization and payments across payers. Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will learn what the code represents clinically, the typical settings where the device is implanted, and what to expect in a national policy and billing context. The publication summarizes benchmarks and coverage trends where available, clarifies coding placement within the HCPCS Level II system, and provides clinical context for the prosthesis’ use in first carpometacarpal total joint replacement. Where payer-specific coverage policies and reimbursement benchmarks are available, they are summarized to aid billing compliance and claims preparation. Data not available in the input is noted explicitly where applicable.
Billing Code Overview
HCPCS Level II code C1608 describes a prosthesis, total, dual mobility, first carpometacarpal joint (implantable). This code represents an implantable orthopedic prosthesis designed for total joint replacement of the first carpometacarpal (thumb base) joint using a dual mobility construct.
Service Type: Orthopedic implant/prosthesis – total joint replacement
Typical Site of Service: Hospital operating room or outpatient surgical center
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is a 65-year-old right-hand-dominant individual with progressive pain, reduced grip strength, and thumb base instability from advanced osteoarthritis of the first carpometacarpal (CMC) joint. Conservative care (activity modification, splinting, NSAIDs, corticosteroid injection) failed to provide durable relief. After surgical evaluation, the patient is scheduled for implantation of a total dual mobility prosthesis for the first carpometacarpal joint (C1608). The procedure is performed in an outpatient ambulatory surgery center or hospital outpatient department with regional or general anesthesia. Preoperative workflow includes history and physical, imaging (radiographs +/- CT), informed consent, medication reconciliation, and prophylactic antibiotics. Intraoperative workflow includes surgical exposure of the first CMC joint, preparation of trapezium and metacarpal surfaces, implantation of the dual mobility components, assessment of stability and range of motion, and wound closure. Postoperative workflow includes immediate recovery, analgesia plan, immobilization in a short thumb spica splint or cast, discharge instructions, and scheduled follow-up for wound check and progressive hand therapy focusing on range of motion and strengthening. Typical payors include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, BUCA, and Medicare; billing reflects implantable device reporting for device tracking and reimbursement under C1608 for the prosthetic implant itself, with separate reporting for surgeon services and facility charges.
Coding Specifications
| Modifier | Description | When to Use |
|---|